Skip to main content
Veterinary Medicines

HIPRASUIS AD

Authorised
  • Aujeszky's disease virus, strain Bartha K61, Inactivated

Product identification

Medicine name:
HIPRASUIS AD
Active substance:
  • Aujeszky's disease virus, strain Bartha K61, Inactivated
Target species:
  • Pigs (for fattening)
  • Pig (female)
  • Pig (male for reproduction)
Route of administration:
  • Intramuscular use
  • Nasal use

Product details

Active substance and strength:
  • Aujeszky's disease virus, strain Bartha K61, Inactivated
    105.50
    cell culture infective dose 50
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pigs (for fattening)
      • Meat and offal
        0
        day
    • Pig (female)
      • Meat and offal
        0
        day
    • Pig (male for reproduction)
      • Meat and offal
        0
        day
  • Nasal use
    • Pigs (for fattening)
      • Meat and offal
        0
        day
    • Pig (female)
      • Meat and offal
        0
        day
    • Pig (male for reproduction)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AD01
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • (AEMPS)
Authorisation number:
  • 3147 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."